Bioequivalence of Tablet Formulation of Dabigatran Etexilate Compared to Commercial Capsule Formulation Following Oral Administration in Healthy Male Subjects
Clinical trial NCT03070171 · COMPLETED
Trial details
- NCT number
- NCT03070171
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-21
- Primary completion
- 2017-06-16
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.